Clinical Ocular Exposure Extrapolation Using PBPK Modeling and Simulation: Besifloxacin Suspension Case Study

被引：0
|
作者：
Le Merdy, Maxime [1 ]
AlQaraghuli, Farah [1 ]
Lukacova, Viera [1 ]
机构：
[1] Simulations Plus Inc, Lancaster, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Utilising in vitro to in vivo extrapolation and PBPK modeling demonstrates how a better understanding of human systemic exposure can establish margins of systemic exposure and be used to refine agrochemical risk assessments
    Stevens, Alexander
    Whalley, Sarah
    Burt, Howard
    Hofstra, Angela
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [42] Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling
    Ankit Balhara
    Mayur K. Ladumor
    Rakesh P. Nankar
    Samiulla Dodheri Syed
    Sanjeev Giri
    Bhagwat Prasad
    Saranjit Singh
    Pharmaceutical Research, 2022, 39 : 677 - 689
  • [43] Study And Simulation on Truck Front Suspension Using ADAMS
    Bao, Weining
    ADVANCES IN MECHATRONICS AND CONTROL ENGINEERING II, PTS 1-3, 2013, 433-435 : 2235 - 2238
  • [44] In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation
    Zhang, Fan
    Zhou, Yinping
    Wu, Ni
    Jia, Ranran
    Liu, Aijing
    Liu, Bo
    Zhou, Zhou
    Hu, Haitang
    Han, Zhihui
    Ye, Xiang
    Ding, Ying
    He, Qing
    Wang, Hongyun
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 157
  • [45] Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - An evaluation and case study using GastroPlus™
    Heikkinen, Aki T.
    Baneyx, Guillaume
    Caruso, Antonello
    Parrott, Neil
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (02) : 375 - 386
  • [46] PROSPECTIVE APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING TO INFORM THE DESIGN OF A CLINICAL DRUG-DRUG INTERACTION (DDI) STUDY: CASE STUDY OF MEZIGDOMIDE
    Burnett, J.
    Sychterz, C.
    Zhu, Y.
    Shakeel, F.
    Dingley, K.
    Chen, W.
    Rajadhyaksha, P.
    Shahane, A.
    Wang, X.
    Gaohua, L.
    Lamba, M.
    Gaudy, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S108 - S108
  • [47] PBPK modeling to evaluate maximum tolerated doses: A case study with 3-chloroallyl alcohol
    Conolly, Rory P.
    Clewell, Harvey J.
    Moore, Martha M.
    Campbell, Jerry L.
    Cheng, Wanyun
    Gentry, R. Robinan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Energy Savings for a Manufacturing Facility Using Building Simulation Modeling:A Case Study
    Moynihan, Gary P.
    Triantafillu, Dimos
    EMJ-ENGINEERING MANAGEMENT JOURNAL, 2012, 24 (04): : 73 - 84
  • [49] Modeling the Food Manufacturing System by using Simulation: A Case Study at XYZ Factory
    Shamsuri, Siti Nur Shahirah Mohd
    Rani, Ruzanita Mat
    PROCEEDINGS OF THE 27TH NATIONAL SYMPOSIUM ON MATHEMATICAL SCIENCES (SKSM27), 2020, 2266
  • [50] Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children
    Traver, Estefania
    Rodriguez-Pascau, Laura
    Meya, Uwe
    Pina, Guillem
    Pascual, Silvia
    Poli, Sonia
    Eckland, David
    van de Wetering, Jeroen
    Ke, Alice
    Lindauer, Andreas
    Martinell, Marc
    Pizcueta, Pilar
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (06): : 982 - 993
12345